Moderna to develop three new mRNA vaccine candidates

Shares of Moderna Inc. MRNA, -3.59% gained 0.1% on Friday after the company said it is now developing mRNA vaccines for herpes simplex virus, varicella-zoster virus (against shingles), and certain types of cancer, starting with advanced or metastatic melanoma and non-small cell lung carcinoma. The company’s stock is down 13.7% over the past year, while the broader S&P 500 SPX, -2.12% is 11.4%.

Source: Marketwatch

DE 40 forecast: the downtrend has ended, but growth momentum is slowing

The growth pace of the DE 40 stock index has slowed. The DE 40 forecast for today is positive. DE 40 forecast: key trading points

USDJPY dips to the 147.00 area

The USDJPY rate is edging lower, falling to 147.00 after hawkish comments from Bank of Japan Governor Kazuo Ueda at the Jackson Hole Symposium. Discover

Market greed has shifted to smaller names

On Friday, speaking in Jackson Hole, Fed Chairman Powell confirmed his readiness to lower the key rate in September. Prior to these statements, expectations that

Moderna to develop three new mRNA vaccine candidates

Related Posts

DE 40 forecast: the downtrend has ended, but growth momentum is slowing

USDJPY dips to the 147.00 area

Market greed has shifted to smaller names

Recent Posts

Leading Key

About

Brokers By Regulator

Forex Brokers List

Trading Tools